ProfileGDS4284 / 236973_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 14% 25% 18% 33% 17% 14% 32% 26% 26% 2% 5% 20% 24% 35% 39% 22% 3% 25% 26% 28% 22% 7% 35% 34% 21% 36% 12% 14% 37% 33% 22% 34% 31% 23% 33% 11% 22% 27% 2% 33% 25% 6% 36% 34% 13% 4% 14% 16% 65% 29% 28% 29% 34% 37% 31% 6% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control20.876214
GSM687648Patient 402 control56.397725
GSM687653Patient 403 control32.012418
GSM687658Patient 404 control95.865333
GSM687663Patient 411 control33.844517
GSM687668Patient 422 control23.975714
GSM687673Patient 424 control92.773232
GSM687678Patient 425 control67.170326
GSM687683Patient 427 control67.762426
GSM687688Patient 428 control5.214252
GSM687695Patient 441 control19.20715
GSM687699Patient 443 control48.487420
GSM687704Patient 444 control53.240924
GSM687707Patient 448 control130.65435
GSM687712Patient 449 control130.92439
GSM687719Patient 450 control58.074722
GSM687724Patient 451 control9.267943
GSM687728Patient 452 control65.135525
GSM687646Patient 401 treated 24h58.954426
GSM687649Patient 402 treated 24h63.001828
GSM687665Patient 411 treated 24h54.271122
GSM687651Patient 402 treated 4 weeks13.12347
GSM687667Patient 411 treated 4 weeks104.88735
GSM687670Patient 422 treated 24h105.14534
GSM687671Patient 422 treated 4 weeks41.017521
GSM687654Patient 403 treated 24h96.254136
GSM687675Patient 424 treated 24h24.312712
GSM687685Patient 427 treated 24h22.581914
GSM687656Patient 403 treated 4 weeks99.773337
GSM687677Patient 424 treated 4 weeks92.874233
GSM687687Patient 427 treated 4 weeks41.435622
GSM687692Patient 428 treated 4h100.74134
GSM687716Patient 449 treated 4h84.364631
GSM687722Patient 450 treated 4h60.125423
GSM687680Patient 425 treated 24h93.994933
GSM687690Patient 428 treated 24h17.406411
GSM687700Patient 443 treated 24h76.113122
GSM687705Patient 444 treated 24h60.592527
GSM687714Patient 449 treated 24h5.39332
GSM687721Patient 450 treated 24h113.9733
GSM687682Patient 425 treated 4 weeks57.428125
GSM687694Patient 428 treated 4 weeks10.10276
GSM687702Patient 443 treated 4 weeks120.69436
GSM687718Patient 449 treated 4 weeks103.53534
GSM687723Patient 450 treated 4 weeks23.298413
GSM687661Patient 404 treated 4h8.985314
GSM687710Patient 448 treated 4h25.101314
GSM687726Patient 451 treated 4h31.811416
GSM687730Patient 452 treated 4h699.05165
GSM687660Patient 404 treated 24h95.997629
GSM687697Patient 441 treated 24h101.4328
GSM687709Patient 448 treated 24h82.741329
GSM687725Patient 451 treated 24h121.77334
GSM687729Patient 452 treated 24h164.18937
GSM687727Patient 451 treated 4 weeks105.11331
GSM687731Patient 452 treated 4 weeks13.55666